Daewoong Pharmaceutical Co Ltd Sustainability Reports
Daewoong Pharmaceutical Co., Ltd. develops, manufactures, and commercializes prescription and over-the-counter pharmaceutical products. Its major treatments focus on metabolic, cardiovascular, gastrointestinal, and central nervous system diseases, alongside botulinum toxin products.
Sector: Manufacturing
Country: South Korea
Exchange: Korea Exchange (KOSPI)
FIGI: BBG001SF5V18
9 reports from 2021 to 2025
